Evaluating a test for upper extremity function in rheumatoid arthritis patients
Official title: Validity and Reliability of the Six-minute Peg Board and Ring Test in Patients With Rheumatoid Arthritis
Run by Kirsehir Ahi Evran Universitesi · NCT06753851 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new six-minute test to see if it can better measure how well people with rheumatoid arthritis use their hands and arms compared to current methods.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Kirsehir Ahi Evran Universitesi Academic / other |
| Locations | 1 site (Kırşehir, Merkez) |
| Trial ID | NCT06753851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-75 diagnosed with rheumatoid arthritis.
✕Probably not a fit
Patients with serious cardiopulmonary, neurological, or orthopedic conditions, or those who have participated in an exercise program in the last three months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the validity and reliability of the six-minute peg board and ring test (6-PBRT) specifically for patients with rheumatoid arthritis (RA). It focuses on understanding how this test can effectively measure upper extremity endurance and functional capacity, which are often compromised in RA patients. By comparing the results of the 6-PBRT with existing measures of grip strength, the study seeks to establish a more comprehensive evaluation method for rehabilitation programs aimed at improving upper extremity function. The study will include patients aged 18-75 who have been diagnosed with RA and are willing to participate.
Why it matters
Potential benefit: If successful, this study could provide a reliable method for assessing upper extremity function in rheumatoid arthritis patients, leading to improved rehabilitation strategies.
How similar studies have gone: While the 6-PBRT has been validated in other populations, its application specifically for rheumatoid arthritis patients is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with rheumatoid arthritis, * Ages of between 18-75 years, * Patients who volunteer to participate in the study will be included in the study. Exclusion Criteria: * Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions, * Participated in a planned exercise program in the last three months, * Cognitive impairment that will cause difficulty in understanding and following exercise test instructions, * Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study.
Where it's running
-
Kırşehir Ahi Evran University, 63 / 5.000 Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit
Kırşehir, Merkez, Turkey Recruiting
Study contacts
- Principal investigator: Başak KAVALCI KOL, PhD, PT — Kirsehir Ahi Evran Universitesi
- Study coordinator: Başak KAVALCI KOL Lecturer, PhD
- Email: basak.kavalci@ahievran.edu.tr
- Phone: 03862802317
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GenAI-assisted RA bone erosion risk and DMARD choice
This study tests whether GenAI-based decision support can help doctors assess rheumatoid arthritis bone erosion risk and pick DMARDs for newly diagnosed inpatients.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Telitacicept for difficult-to-treat rheumatoid arthritis
This study tests whether adding telitacicept to standard therapy helps adults with hard-to-treat rheumatoid arthritis see better control of their symptoms.
-
PTC844 in people with active rheumatoid arthritis
This study tests whether PTC844 is safe and how it behaves in the body compared with placebo for people with active rheumatoid arthritis.
-
First-in-human test of CND319 in healthy people and people with rheumatic diseases
This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.
-
IV sarilumab for adults with rheumatoid arthritis
This study tests IV sarilumab to see how it works and how safe it is for adults with moderately to severely active rheumatoid arthritis, with or without certain standard arthritis medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.